ALKBH5 and nonpapillary renal cell carcinoma: Thorough evaluation of the global expression of all regulators demonstrated that erasers (FTO and ALKBH5) are highly expressed in RCC compared to writers (METTL3/14, WTAP and VIRMA), specifically in ccRCC, prompting further investigation in an independent patient (IPO Porto) cohort.